Session 3: $399

  • Exercises in due diligence, financial analysis, determination of valuation & terms
  • Real case studies
  • Final exam – optional

By session end, you will understand:

  • How to conduct due diligence from A-Z of both early and later stage ventures,  including review of financials, determination of valuation and negotiation of ideal terms.
  • Thru case studies, gain insight into how actual investment firms evaluated deals and what ultimately led to their investment decisions

Course 3 Registration - 45 day access

  • Price: $399.00
    Refund Policy: 100% within 24 hours of purchase. 50% within 48 hours of purchase. No refund thereafter. Limitation of Liability: This online course does not endorse or make any representations or warranties concerning companies presented. Content of all lessons is for educational purposes only. The organizers disclaim any liability for investment losses or damages flowing from Participant’s individual investment decisions. Participants should obtain independent legal and financial advice prior to making any investment decision. All Participants understand that they will hold harmless the course organizers, instructors, sponsors and ECF Biosolutions for any investment decisions which result in a loss. The course organizers, instructors, sponsors and ECF Biosolutions do not constitute a venture fund, investment bank, broker/dealer, investment clearinghouse, or any other form of investment advisor or otherwise, and are not registered with the Securities and Exchange Commission or any state securities commission. They do not provide advice, recommendations, or any other indications of appropriateness or inappropriateness for a particular investment. Confidentiality of Material: All educational content is being furnished on a confidential basis. By accepting the material, the registrant agrees to keep confidential the information contained herein. Any unauthorized use, distribution, or reproduction of the material is prohibited. All sales are final.
  • American Express
  • $0.00


Djamil Fertikh, MD

  • Partner, Assn of Alexandria Radiologists
  • Angel Investor, MEDA Angels

Djamil Fertikh, MD, is a board-certified neuroradiologist. He is a Partner at the Association of Alexandria Radiologists in Alexandria, VA and serves on the Finance Committee. Dr. Fertikh has maintained a diversified portfolio of investments in publicly traded companies as well as privately held start-ups across a variety of sectors, including the biotech, consumer, artificial intelligence & SaaS sectors, as an active angel investor.

Ben Lieblich, JD, MBA

  • Partner & COO, GP Ventures

Multi-faceted career spanning politics, law, finance, start-up & venture capital worlds. Has served as the CFO or as a Financial consultant for more than a dozen enterprises including Cleveland Clinic, Likeable Media & Streamline MD, a company which he co-founded and served as President.  At GP Ventures, Ben sources investments and oversees the fund’s due diligence process and operations.  BA, Columbia; JD, Harvard Law;  MBA, Georgetown McDonough Business.

Carolyn Campbell, PhD, JD

  • Managing Director & Founding Partner, ECP Investments

Overall management oversight of operations & investments at ECP Investments, one of the leading private equity fund focused on Africa with 7 funds and over $2 billion under mgmt, w/over >60 investments operating in 45 countries. Carolyn serves on the boards of several portfolio companies in the energy, financial services and natural resources sector. Prior to joining ECP in 2000, Carolyn was a senior associate at White & Case, LLP, law firm.  She is a member of the Council on Foreign Relations.  BA, U of Conn; PhD, Oxford; JD, University of VA.

Elizabeth Cho-Fertikh, PhD

Founder, ECF Biosolutions
Co Founder & Managing Director, MEDA Angels

Angel investor & venture capital partner.  20 years cancer research, high impact scientific journal publications, biotech R&D, regulatory and management experience for dozens of start-ups and industry, including MacroGenics, Gore Medical, Beckman Coulter, Amgen.  BA, Johns Hopkins, PhD, Thomas Jefferson University, Postdoctoral Training, Harvard Medical School.